Literature DB >> 18317788

Novel treatment of atrophic rhinitis: early results.

Abhishek Jaswal1, Avik Kumar Jana, Biswajit Sikder, Tapan K Nandi, Sanjoy Kumar Sadhukhan, Anjan Das.   

Abstract

The aim of this randomized control trial, performed at a tertiary referral hospital, was to compare the therapeutic effectiveness of two novel treatment modalities, oral rifampicin and submucosal placentrex injection, in randomly selected patients of primary atrophic rhinitis regarding objective, subjective and histopathological improvement. Patients treated with oral rifampicin showed most promising results regarding objective, subjective and histopathological improvement with maximum disease-free interval on regular follow-up as compared to submucosal placentrex injections.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18317788     DOI： 10.1007/s00405-008-0629-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


  17 in total

1.  A nine years' review of 273 cases of atrophic rhinitis and its management.

Authors:  S N Sinha; D S Sardana; V S Rajvanshi
Journal:  J Laryngol Otol       Date:  1977-07       Impact factor: 1.469

2.  Histopathological and histochemical studies on atrophic rhinitis.

Authors:  M TAYLOR; A YOUNG
Journal:  J Laryngol Otol       Date:  1961-06       Impact factor: 1.469

3.  The etiology of ozaena.

Authors:  S D HENRIKSEN; W B GUNDERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1959

4.  Placental extract therapy in atrophic rhinitis.

Authors:  S N Sinha; S C Gupta; K C Samuel; U C Misra
Journal:  Eye Ear Nose Throat Mon       Date:  1976-01

5.  Ozena revisited.

Authors:  Y Zohar; Y P Talmi; M Strauss; Y Finkelstein; Y Shvilli
Journal:  J Otolaryngol       Date:  1990-10

Review 6.  Atrophic rhinitis.

Authors:  W S Goodman; F M De Souza
Journal:  Otolaryngol Clin North Am       Date:  1973-10       Impact factor: 3.346

7.  Histopathological and histochemical studies on atrophic rhinitis.

Authors:  A Yassin; H Fouad; M el-Shennawy
Journal:  J Laryngol Otol       Date:  1970-11       Impact factor: 1.469

8.  Successful treatment of ozena with ciprofloxacin.

Authors:  B C Nielsen; A M Olinder-Nielsen; A S Malmborg
Journal:  Rhinology       Date:  1995-06       Impact factor: 3.681

9.  The ozena problem. Clinical analysis of atrophic rhinitis in 100 cases.

Authors:  C Han-Sen
Journal:  Acta Otolaryngol       Date:  1982 May-Jun       Impact factor: 1.494

10.  Atrophic rhinitis: antibiotic treatment.

Authors:  J P Dudley
Journal:  Am J Otolaryngol       Date:  1987 Nov-Dec       Impact factor: 1.808
View more
  4 in total

1.  Is submucosal fat injection effective in atrophic rhinitis? An experimental animal study.

Authors:  Mehmet Beyhan Balur; Hasan Emre Koçak; Serdar Altınay; Kadir Özdamar; Ümit Taşkın; Mehmet Faruk Oktay
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-13       Impact factor: 2.503

2.  Chemosensory function assessed with psychophysical testing and event-related potentials in patients with atrophic rhinitis.

Authors:  C Huart; Ph Eloy; S Collet; Ph Rombaux
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-30       Impact factor: 2.503

3.  Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses.

Authors:  Achim G Beule
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27

4.  Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique.

Authors:  Charles-Henri Hassan; Emeline Malheiro; Emilie Béquignon; André Coste; Sophie Bartier
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.